Who owns Sionna Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SION from SEC Form 13F filings across 136 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 136 institutions disclosed 45.6M shares of Sionna Therapeutics, Inc. worth $239.7M — about 100.8% of shares outstanding; the largest disclosed holder is TPG GP A, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
136
13F holders
$239.7M
value, 2026 filers
100.8%
of shares outstanding (45.6M sh)
45
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SION's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TPG GP A, LLC | 6.5M | $34.2M | 0.8% | 14.4% | 0.0% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 6.5M | $34.0M | 0.3% | 14.3% | -34.8% |
| 3 | VIKING GLOBAL INVESTORS LP | 3.2M | $16.8M | 0.1% | 7.1% | 0.0% |
| 4 | Atlas Venture Life Science Advisors, LLC | 3.0M | $15.8M | 2.5% | 6.6% | 0.0% |
| 5 | GOLDMAN SACHS GROUP INC | 2.7M | $14.3M | 0.0% | 6% | +599.6% |
| 6 | BlackRock, Inc. | 2.7M | $14.1M | 0.0% | 5.9% | +81.4% |
| 7 | ENAVATE SCIENCES GP, LLC | 2.5M | $13.0M | 4.7% | 5.5% | 0.0% |
| 8 | ORBIMED ADVISORS LLC | 2.5M | $13.0M | 0.2% | 5.5% | -3.4% |
| 9 | JENNISON ASSOCIATES LLC | 2.0M | $10.5M | 0.0% | 4.4% | +70.0% |
| 10 | MILLENNIUM MANAGEMENT LLC | 1.5M | $7.7M | 0.0% | 3.2% | +428.6% |
| 11 | Aberdeen Group plc | 1.3M | $7.1M | 0.0% | 3% | +372.7% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $6.3M | 0.0% | 2.6% | +5.1% |
| 13 | Y-Intercept (Hong Kong) LtdNEW | 1.1M | $5.6M | 0.1% | 2.3% | new |
| 14 | ACADIAN ASSET MANAGEMENT LLCNEW | 553,956 | $2.9M | 0.0% | 1.2% | new |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 539,509 | $2.8M | 0.0% | 1.2% | +18.0% |
| 16 | Walleye Capital LLC | 453,319 | $2.4M | 0.0% | 1% | +365.7% |
| 17 | MARSHALL WACE, LLP | 444,016 | $2.3M | 0.0% | 1% | +3424.2% |
| 18 | Voleon Capital Management LPNEW | 429,584 | $2.3M | 0.0% | 1% | new |
| 19 | Boxer Capital Management, LLCNEW | 391,723 | $2.1M | 0.2% | 0.9% | new |
| 20 | BANK OF AMERICA CORP /DE/ | 378,110 | $2.0M | 0.0% | 0.8% | +325.3% |
| 21 | STATE STREET CORP | 377,179 | $2.0M | 0.0% | 0.8% | -63.1% |
| 22 | AQR CAPITAL MANAGEMENT LLCNEW | 326,393 | $1.7M | 0.0% | 0.7% | new |
| 23 | MORGAN STANLEY | 303,883 | $1.6M | 0.0% | 0.7% | +101.2% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 299,620 | $1.6M | 0.0% | 0.7% | +34.4% |
| 25 | Point72 Asset Management, L.P. | 263,401 | $1.4M | 0.0% | 0.6% | +434.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.